APTA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Aptahem operates in the pharmaceutical industry. The company develops aptamer-based drugs for the treatment of acute life-threatening conditions where coagulation and inflammation interact in the disease process. The company's lead candidate is being developed as an emergency drug intended to prevent the onset of life-threatening organ and tissue damage in patients suffering from sepsis. A large part of the research is carried out in collaboration with partners in the industry. The company was founded in 2014 and is headquartered in Malmö.
Læs mereEPS (adj.)
Udbytte %
Delårsrapport Q2'26
Gå ikke glip af noget - opret en konto og få alle de mulige fordele